Enabling cures for liver disease through highly predictive in vitro modelling
-
In-house drug screening platformMove even faster by screening your candidates on our ready-to-use validated hepatocyte disease models >Find out more -
Bespoke disease model and bioassay developmentOur novel platform can generate custom disease models and supporting bioassays that can accurately evaluate compound potency, efficacy and deliverySee Disease Modeling Services -
Trusted partnerWe collaborate with your team to deliver world-class scienceLearn more about us
Cell-Based Bioassays
Our cell-based bioassays are developed following industry guidelines on bioanalytical method validation.
Specialist CRO focused on delivering phenotypically relevant liver disease models
Physiologically relevant liver disease models that can be generated at scale for modeling, assay development and screening.
Advance your programme at speed with our in-house drug screening platform
By combining our expertise at generating iPSC-derived hepatocyte cellular models of disease with our wide panel of bespoke bioassays.
We work as partners with your team to design and implement in-house screening of small molecule and advanced genetic therapies, so you can advance your program at speed.
-
Alpha-1 antitrypsin deficiencyOptimised bioassays for the preclinical screening of small molecules, siRNA and oligo therapeutic candidates and base editing approachesView Case Study > -
Wilson's diseaseOptimised bioassays for the preclinical screening of small molecules, siRNA and oligo therapeutic candidates and base editing approachesView Case Study > -
Custom Phenotypic AssaysCustom model and assay development available. Get in touch with your project specific requirements today.Contact Us
